TABLE OF CONTENTS
1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 OVERVIEW OF MIDDLE EAST & AFRICA COLORECTAL SURGICAL DEVICES MARKET 24
1.4 LIMITATIONS 25
1.5 MARKETS COVERED 25
2 MARKET SEGMENTATION 27
2.1 MARKETS COVERED 27
2.2 GEOGRAPHICAL SCOPE 28
2.3 YEARS CONSIDERED FOR THE STUDY 29
2.4 CURRENCY AND PRICING 29
2.5 DBMR TRIPOD DATA VALIDATION MODEL 30
2.6 MULTIVARIATE MODELLING 33
2.7 PRODUCT TYPE LIFELINE CURVE 33
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 34
2.9 DBMR MARKET POSITION GRID 35
2.10 MARKET APPLICATION COVERAGE GRID 36
2.11 VENDOR SHARE ANALYSIS 37
2.12 SECONDARY SOURCES 38
2.13 ASSUMPTIONS 38
3 EXECUTIVE SUMMARY 39
4 PREMIUM INSIGHTS 42
4.1 PESTEL ANALYSIS 43
4.2 PORTERS FIVE FORCES 44
5 INDUSTRIAL INSIGHTS: 45
CONCLUSION: 45
6 MIDDLE EAST & AFRICA COLORECTAL SURGICAL DEVICES MARKET: REGULATIONS 46
6.1 REGULATION IN U.S 46
6.2 REGULATION IN EUROPE 47
6.3 REGULATION IN CANADA 47
6.4 REGULATION IN SOUTH AFRICA 48

7 MARKET OVERVIEW 49
7.1 DRIVERS 51
7.1.1 INCREASE IN GERIATRIC POPULATION 51
7.1.2 RISE IN NUMBER OF PATIENTS SUFFERING FROM DIVERTICULITIS AND ULCERATIVE COLITIS 51
7.1.3 INCREASE IN HEALTHCARE EXPENDITURE 52
7.1.4 RISE IN PREVALENCE OF COLORECTAL CANCER 53
7.2 RESTRAINTS 54
7.2.1 HIGH COST OF COLORECTAL SURGERY DEVICES 54
7.2.2 STRICT REGULATIONS 54
7.3 OPPORTUNITIES 55
7.3.1 STRATEGIC INITIATIVES TAKEN BY MARKET PLAYERS AND GOVERNMENT 55
7.3.2 INCREASE IN MINIMAL INVASIVE SURGERY PROCEDURE 55
7.3.3 RISING DISPOSABLE INCOME 56
7.4 CHALLENGES 56
7.4.1 COMPLICATIONS ASSOCIATED WITH PROCEDURE 56
1.4.1 SHORTAGE OF SKILLED PERSONNEL 57
8 MIDDLE EAST & AFRICA COLORECTAL SURGICAL DEVICES MARKET, BY PRODUCT TYPE 58
8.1 OVERVIEW 59
8.2 ENDOSCOPE 62
8.2.1 LAPAROSCOPE 63
8.2.2 COLONSCOPE 63
8.3 ELECTROSURGERY 63
8.3.1 INSTRUMENTS 64
8.3.2 ACCESSORIES 64
8.4 HANDHELD INSTRUMENTS 64
8.4.1 SCISSORS 65
8.4.2 FORCEPS 65
8.4.3 OTHERS 65
8.5 SEALING DEVICES 66
8.6 SURGICAL STAPLING DEVICES 67
8.7 ACCESSORIES 68

9 MIDDLE EAST & AFRICA COLORECTAL SURGICAL DEVICES MARKET, BY INDICATION 69
9.1 OVERVIEW 70
9.2 COLORECTAL CANCER 73
9.3 DIVERTICULITIS 74
9.4 ULCERATIVE COLITIS 75
9.5 CROHN'S DISEASE 76
9.6 OTHERS 77
10 MIDDLE EAST & AFRICA COLORECTAL SURGICAL DEVICES MARKET, BY END USER 78
10.1 OVERVIEW 79
10.2 SURGICAL CENTERS 82
10.3 HOSPITALS 83
10.4 CLINICS 84
10.5 OTHERS 85
11 MIDDLE EAST & AFRICA COLORECTAL SURGICAL DEVICES MARKET, BY REGION 86
11.1 MIDDLE EAST AND AFRICA 87
11.1.1 SOUTH AFRICA 93
11.1.2 SAUDI ARABIA 95
11.1.3 U.A.E. 97
11.1.4 ISRAEL 99
11.1.5 EGYPT 101
11.1.6 REST OF MIDDLE EAST AND AFRICA 103
12 MIDDLE EAST & AFRICA COLORECTAL SURGICAL DEVICES MARKET: COMPANY LANDSCAPE 104
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 104
13 COMPANY PROFILE 105
13.1 MEDTRONIC 105
13.1.1 COMPANY SNAPSHOT 105
13.1.2 REVENUE ANALYSIS 106
13.1.3 COMPANY SHARE ANALYSIS 106
13.1.4 PRODUCT PORTFOLIO 106
13.1.5 RECENT DEVELOPMENT 107
13.1.5.1 PRODUCT LAUNCH 107

13.2 STRYKER 108
13.2.1 COMPANY SNAPSHOT 108
13.2.2 REVENUE ANALYSIS 108
13.2.3 COMPANY SHARE ANALYSIS 109
13.2.4 PRODUCT PORTFOLIO 109
13.2.5 RECENT DEVELOPMENTS 110
13.2.5.1 ACQUISITION 110
13.3 JOHNSON & JOHNSON SERVICES, INC 111
13.3.1 COMPANY SNAPSHOT 111
13.3.2 REVENUE ANALYSIS 111
13.3.3 COMPANY SHARE ANALYSIS 112
13.3.4 PRODUCT PORTFOLIO 112
13.3.5 RECENT DEVELOPMENTS 112
13.3.5.1 FDA CLEARANCE 112
13.3.5.2 STUDY RESULTS 112
13.4 BOSTON SCIENTIFIC CORPORATION 114
13.4.1 COMPANY SNAPSHOT 114
13.4.2 REVENUE ANALYSIS 114
13.4.3 COMPANY SHARE ANALYSIS 115
13.4.4 PRODUCT PORTFOLIO 115
13.4.5 RECENT DEVELOPMENTS 115
13.4.5.1 PRODUCT LAUNCH 115
13.4.5.2 AGREEMENT 116
13.5 KARL STORZ SE & CO. KG 117
13.5.1 COMPANY SNAPSHOT 117
13.5.2 COMPANY SHARE ANALYSIS 117
13.5.3 PRODUCT PORTFOLIO 118
13.5.4 RECENT DEVELOPMENTS 118
13.5.4.1 CONTRACT 118
13.5.4.2 INVESTMENT 119
13.6 BD 120
13.6.1 COMPANY SNAPSHOT 120
13.6.2 REVENUE ANALYSIS 120
13.6.3 PRODUCT PORTFOLIO 121
13.6.4 RECENT DEVELOPMENT 121
13.6.4.1 ACQUISITION 121

13.7 BIPAD SURGICAL, INC 122
13.7.1 COMPANY SNAPSHOT 122
13.7.2 PRODUCT PORTFOLIO 122
13.7.3 RECENT DEVELOPMENT 122
13.7.3.1 FDA APPROVAL 122
13.8 CARDINAL HEALTH 123
13.8.1 COMPANY SNAPSHOT 123
13.8.2 REVENUE ANALYSIS 123
13.8.3 PRODUCT PORTFOLIO 124
13.8.4 RECENT DEVELOPMENTS 124
13.8.4.1 NEW DISTRIBUTION CENTER 124
13.8.4.2 NEW DISTRIBUTION CENTER 124
13.9 COOK GROUP 125
13.9.1 COMPANY SNAPSHOT 125
13.9.2 PRODUCT PORTFOLIO 125
13.9.3 RECENT DEVELOPMENTS 126
13.9.3.1 ISO CERTIFICATION 126
13.9.3.2 INVESTMENT 126
13.10 CONMED CORPORATION 127
13.10.1 COMPANY SNAPSHOT 127
13.10.2 REVENUE ANALYSIS 127
13.10.3 PRODUCT PORTFOLIO 128
13.10.4 RECENT DEVELOPMENT 128
13.10.4.1 CONFERENCE 128
13.11 HALLMARK SURGICAL 129
13.11.1 COMPANY SNAPSHOT 129
13.11.2 PRODUCT PORTFOLIO 129
13.11.3 RECENT DEVELOPMENT 129
13.12 HEBSON 130
13.12.1 COMPANY SNAPSHOT 130
13.12.2 PRODUCT PORTFOLIO 130
13.12.3 RECENT DEVELOPMENT 130
13.13 OLYMPUS CORPORATION 131
13.13.1 COMPANY SNAPSHOT 131
13.13.2 REVENUE ANALYSIS 131
13.13.3 PRODUCT PORTFOLIO 132
13.13.4 RECENT DEVELOPMENT 132
13.13.4.1 PRODUCT LAUNCH 132

13.14 OVESCO ENDOSCOPY AG 133
13.14.1 COMPANY SNAPSHOT 133
13.14.2 PRODUCT PORTFOLIO 133
13.14.3 RECENT DEVELOPMENT 133
13.14.3.1 MARKET APPROVAL 133
13.15 PENTAX MEDICAL 134
13.15.1 COMPANY SNAPSHOT 134
13.15.2 REVENUE ANALYSIS 134
13.15.3 PRODUCT PORTFOLIO 135
13.15.4 RECENT DEVELOPMENTS 135
13.15.4.1 JOINT VENTURE 135
13.16 RICHARD WOLF GMBH 136
13.16.1 COMPANY SNAPSHOT 136
13.16.2 PRODUCT PORTFOLIO 136
13.16.3 RECENT DEVELOPMENT 136
13.16.3.1 NEW SUBSIDIARY 136
13.17 SAFEHEAL 137
13.17.1 COMPANY SNAPSHOT 137
13.17.2 PRODUCT PORTFOLIO 137
13.17.3 RECENT DEVELOPMENT 137
13.17.3.1 PARTNERSHIP 137
13.18 SMITH + NEPHEW 138
13.18.1 COMPANY SNAPSHOT 138
13.18.2 REVENUE ANALYSIS 138
13.18.3 PRODUCT PORTFOLIO 139
13.18.4 RECENT DEVELOPMENT 139
13.18.4.1 FDA APPROVAL 139
13.19 SUMMIT HILL LABORATORIES 140
13.19.1 COMPANY SNAPSHOT 140
13.19.2 PRODUCT PORTFOLIO 140
13.19.3 RECENT DEVELOPMENT 140
13.20 SYMMETRY SURGICAL, INC 141
13.20.1 COMPANY SNAPSHOT 141
13.20.2 PRODUCT PORTFOLIO 141
13.20.3 RECENT DEVELOPMENTS 142
13.20.3.1 ACQUISITION 142

13.21 TELEFLEX INCORPORATED 143
13.21.1 COMPANY SNAPSHOT 143
13.21.2 REVENUE ANALYSIS 143
13.21.3 PRODUCT PORTFOLIO 144
13.21.4 RECENT DEVELOPMENT 144
13.21.4.1 CONFERENCE 144
13.22 THE COOPER COMPANIES INC. 145
13.22.1 COMPANY SNAPSHOT 145
13.22.2 REVENUE ANALYSIS 145
13.22.3 PRODUCT PORTFOLIO 146
13.22.4 RECENT DEVELOPMENTS 146
13.22.4.1 ACQUISITION 146
13.23 W. L. GORE & ASSOCIATES, INC 147
13.23.1 COMPANY SNAPSHOT 147
13.23.2 PRODUCT PORTFOLIO 147
13.23.3 RECENT DEVELOPMENT 147
14 QUESTIONNAIRE 148
15 RELATED REPORTS 150

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.